1. Home
  2. ACAD vs AMED Comparison

ACAD vs AMED Comparison

Compare ACAD & AMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACAD
  • AMED
  • Stock Information
  • Founded
  • ACAD 1993
  • AMED 1982
  • Country
  • ACAD United States
  • AMED United States
  • Employees
  • ACAD N/A
  • AMED N/A
  • Industry
  • ACAD Biotechnology: Pharmaceutical Preparations
  • AMED Medical/Nursing Services
  • Sector
  • ACAD Health Care
  • AMED Health Care
  • Exchange
  • ACAD Nasdaq
  • AMED Nasdaq
  • Market Cap
  • ACAD 2.6B
  • AMED 2.9B
  • IPO Year
  • ACAD 2004
  • AMED N/A
  • Fundamental
  • Price
  • ACAD $16.30
  • AMED $86.27
  • Analyst Decision
  • ACAD Buy
  • AMED Hold
  • Analyst Count
  • ACAD 19
  • AMED 5
  • Target Price
  • ACAD $26.44
  • AMED $100.67
  • AVG Volume (30 Days)
  • ACAD 1.4M
  • AMED 661.4K
  • Earning Date
  • ACAD 11-06-2024
  • AMED 11-06-2024
  • Dividend Yield
  • ACAD N/A
  • AMED N/A
  • EPS Growth
  • ACAD N/A
  • AMED 3058.49
  • EPS
  • ACAD 0.78
  • AMED 2.52
  • Revenue
  • ACAD $929,236,000.00
  • AMED $2,321,060,000.00
  • Revenue This Year
  • ACAD $37.34
  • AMED $7.00
  • Revenue Next Year
  • ACAD $7.25
  • AMED $5.43
  • P/E Ratio
  • ACAD $21.00
  • AMED $34.24
  • Revenue Growth
  • ACAD 47.06
  • AMED 4.19
  • 52 Week Low
  • ACAD $14.15
  • AMED $85.84
  • 52 Week High
  • ACAD $32.59
  • AMED $98.95
  • Technical
  • Relative Strength Index (RSI)
  • ACAD 51.17
  • AMED 21.23
  • Support Level
  • ACAD $16.02
  • AMED $90.37
  • Resistance Level
  • ACAD $16.68
  • AMED $91.98
  • Average True Range (ATR)
  • ACAD 0.58
  • AMED 1.22
  • MACD
  • ACAD -0.09
  • AMED -0.11
  • Stochastic Oscillator
  • ACAD 25.70
  • AMED 7.00

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

About AMED Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Share on Social Networks: